Highlights
NASDAQ: GNOM       Global X Genomics & Biotechnology ETF
Last Price Today's Change   Day's Range   Trading Volume
13.929   +0.214 (1.56%)  13.82 - 14.266  1,900

Overview

 
Avg Volume (4 weeks):1,540
4 Weeks Range:12.89 - 14.266
4 Weeks Price Volatility (%):
75.51%
52 Weeks Range:11.881 - 15.39
52 Weeks Price Volatility (%):
58.36%
Average Price Target: 3.00
Price Target Upside/Downside: -10.929

Headlines



No recent Headlines for this stock.


Business Background

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers